{{Rsnum
|rsid=890336
|Gene=CNDP2
|Chromosome=18
|position=74520377
|Orientation=minus
|GMAF=0.1051
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CNDP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 83.9 | 16.1 | 0.0
| JPT | 84.1 | 15.9 | 0.0
| YRI | 34.7 | 54.4 | 10.9
| ASW | 49.1 | 43.9 | 7.0
| CHB | 83.9 | 16.1 | 0.0
| CHD | 81.7 | 18.3 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 47.3 | 40.0 | 12.7
| MEX | 96.6 | 3.4 | 0.0
| MKK | 57.1 | 35.9 | 7.1
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19373489
|Title=The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}